» Articles » PMID: 35742859

Identification of Novel Genes for Cell Fusion During Osteoclast Formation

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jun 24
PMID 35742859
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoclasts are derived from hematopoietic stem cells. Monocyte preosteoclasts obtain resorbing activity via cell-cell fusion to generate multinucleated cells. However, the mechanisms and molecules involved in the fusion process are poorly understood. In this study, we performed RNA sequencing with single nucleated cells (SNCs) and multinucleated cells (MNCs) to identify the fusion-specific genes. The SNCs and MNCs were isolated under the same conditions during osteoclastogenesis with the receptor activator of nuclear factor-κB ligand (RANKL) administration. Based on this analysis, the expression of seven genes was found to be significantly increased in MNCs but decreased in SNCs, compared to that in bone marrow-derived macrophages (BMMs). We then generated knockout macrophage cell lines using a CRISPR-Cas9 genome-editing tool to examine their function during osteoclastogenesis. -, -, or -deficient cells could not develop multinucleated giant osteoclasts upon RANKL stimulation. However, -deficient cells fused more efficiently than control cells. Our findings demonstrate that Calcrl, Marco, and Ube3a are novel determinants of osteoclastogenesis, especially with respect to cell fusion, and highlight potential targets for osteoporosis therapy.

Citing Articles

Attenuating bone loss in osteoporosis: the potential of corylin (CL) as a therapeutic agent.

Zhou S, Huang J, Chen K, Wang Q, Liu Z, Sun Y Aging (Albany NY). 2024; 16(11):9569-9583.

PMID: 38862240 PMC: 11210224. DOI: 10.18632/aging.205885.


Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.

Yang T, Chen W, Gan K, Wang C, Xie X, Su Y J Transl Med. 2023; 21(1):839.

PMID: 37993937 PMC: 10664306. DOI: 10.1186/s12967-023-04706-2.

References
1.
An E, Narayanan M, Manes N, Nita-Lazar A . Characterization of functional reprogramming during osteoclast development using quantitative proteomics and mRNA profiling. Mol Cell Proteomics. 2014; 13(10):2687-704. PMC: 4188996. DOI: 10.1074/mcp.M113.034371. View

2.
McDonald M, Khoo W, Ng P, Xiao Y, Zamerli J, Thatcher P . Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell. 2021; 184(5):1330-1347.e13. PMC: 7938889. DOI: 10.1016/j.cell.2021.02.002. View

3.
Kim J, Lin C, Stavre Z, Greenblatt M, Shim J . Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020; 9(9). PMC: 7564526. DOI: 10.3390/cells9092073. View

4.
Pereira M, Petretto E, Gordon S, Bassett J, Williams G, Behmoaras J . Common signalling pathways in macrophage and osteoclast multinucleation. J Cell Sci. 2018; 131(11). DOI: 10.1242/jcs.216267. View

5.
Teitelbaum S . Bone resorption by osteoclasts. Science. 2000; 289(5484):1504-8. DOI: 10.1126/science.289.5484.1504. View